These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 9052892

  • 1. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide.
    Siragy HM, Jaffa AA, Margolius HS.
    Hypertension; 1997 Mar; 29(3):757-62. PubMed ID: 9052892
    [Abstract] [Full Text] [Related]

  • 2. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
    Munoz-Garcia R, Maeso R, Rodrigo E, Navarro J, Ruilope LM, Casal MC, Cachofeiro V, Lahera V.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
    [Abstract] [Full Text] [Related]

  • 3. Effects of bradykinin on renal nerve stimulation-induced antidiuresis and norepinephrine overflow in anesthetized dogs.
    Tadano K, Yamasaki T, Matsumura Y.
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):461-70. PubMed ID: 11300659
    [Abstract] [Full Text] [Related]

  • 4. Renal haemodynamic and excretory responses to bradykinin in anaesthetized dogs.
    Matsumura Y, Tadano K, Yamasaki T.
    Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):645-50. PubMed ID: 10474781
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide alters renal function and guanosine 3',5'-cyclic monophosphate.
    Siragy HM, Johns RA, Peach MJ, Carey RM.
    Hypertension; 1992 Jun; 19(6 Pt 2):775-9. PubMed ID: 1317356
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
    Brouwers S, Smolders I, Massie A, Dupont AG.
    Hypertension; 2013 Nov; 62(5):920-6. PubMed ID: 24041944
    [Abstract] [Full Text] [Related]

  • 7. Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs.
    Bélichard P, Loillier B, Paquet JL, Luccarini JM, Pruneau D.
    Br J Pharmacol; 1996 Apr; 117(7):1565-71. PubMed ID: 8730755
    [Abstract] [Full Text] [Related]

  • 8. Renin-angiotensin system modulates renal bradykinin production.
    Siragy HM, Jaffa AA, Margolius HS, Carey RM.
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R1090-5. PubMed ID: 8898005
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
    Malomvölgyi B, Hadházy P, Tekes K, Koltai MZ, Pogátsa G.
    Acta Physiol Hung; 1996 Oct; 84(1):9-18. PubMed ID: 8993670
    [Abstract] [Full Text] [Related]

  • 10. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP, Oyama TT, Thompson MM, Anderson S.
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [Abstract] [Full Text] [Related]

  • 11. AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism.
    Hornig B, Kohler C, Schlink D, Tatge H, Drexler H.
    Hypertension; 2003 May; 41(5):1092-5. PubMed ID: 12654707
    [Abstract] [Full Text] [Related]

  • 12. Effects of icatibant on the ramipril-induced decreased in renal lithium clearance in the rat.
    Bagaté K, Grima M, De Jong W, Imbs JL, Barthelmebs M.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):281-7. PubMed ID: 11284442
    [Abstract] [Full Text] [Related]

  • 13. Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin.
    Lahera V, Salom MG, Fiksen-Olsen MJ, Romero JC.
    Am J Hypertens; 1991 Mar; 4(3 Pt 1):260-2. PubMed ID: 2043304
    [Abstract] [Full Text] [Related]

  • 14. Evidence that intrarenal bradykinin plays a role in regulation of renal function.
    Siragy HM.
    Am J Physiol; 1993 Oct; 265(4 Pt 1):E648-54. PubMed ID: 8238340
    [Abstract] [Full Text] [Related]

  • 15. Effects of bradykinin and icatibant on renal hemodynamics in conscious spontaneously hypertensive and normotensive rats.
    Braun C, Ade M, Unger T, van der Woude FJ, Rohmeiss P.
    J Cardiovasc Pharmacol; 1997 Oct; 30(4):446-54. PubMed ID: 9335403
    [Abstract] [Full Text] [Related]

  • 16. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
    Kramer HJ, Horacek V, Bäcker A, Vaneckova I, Heller J.
    Kidney Blood Press Res; 2004 Oct; 27(1):10-7. PubMed ID: 14583658
    [Abstract] [Full Text] [Related]

  • 17. Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway.
    Turner PJ, Maggs JR, Foreman JC.
    Br J Pharmacol; 2000 Sep; 131(2):363-9. PubMed ID: 10991932
    [Abstract] [Full Text] [Related]

  • 18. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.
    Spahr L, Martin PY, Giostra E, Niederberger M, Lang U, Capponi A, Hadengue A.
    J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940
    [Abstract] [Full Text] [Related]

  • 19. Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide.
    Figini M, Ricciardolo FL, Javdan P, Nijkamp FP, Emanueli C, Pradelles P, Folkerts G, Geppetti P.
    Am J Respir Crit Care Med; 1996 Mar; 153(3):918-23. PubMed ID: 8630573
    [Abstract] [Full Text] [Related]

  • 20. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG, Thiemermann C.
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.